Advances in the management of patients with IDH-mutant glioma
This review underscores the importance of a multidisciplinary, precision medicine approach in optimizing outcomes for patients with IDH-mutant gliomas.
Authors
- Giulia Berzero (ORCID: https://orcid.org/0000-0001-8798-9058)
- Jessica Rossi (ORCID: https://orcid.org/0000-0002-1856-7422)
- Orazio Santo Santonocito (ORCID: https://orcid.org/0000-0002-1071-7166)
- Marc Sanson (ORCID: https://orcid.org/0000-0002-1813-8476)
- Anna Luisa Di Stefano (ORCID: https://orcid.org/0000-0003-1746-0647)
- Alberto Pïcca (ORCID: https://orcid.org/0000-0001-7807-5393)
- Lorenzo Testaverde
- Silvia Schembari
Institutions
- University of Modena and Reggio Emilia (IT)
- Sorbonne Université (FR)
- Azienda Sanitaria Unità Locale di Reggio Emilia (IT)
- Istituto Clinico Sant'Ambrogio (IT)
- Pitié-Salpêtrière Hospital (FR)
- IRCCS Ospedale San Raffaele (IT)
- Ospedale di Livorno (IT)
Publication Details
- Journal
- The Oncologist
- Published
- 2025-11-21
- DOI
- https://doi.org/10.1093/oncolo/oyaf391
- Primary Topic
- Glioma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00